PL1633189T3 - Skrócone fragmenty alfa-synukleiny w chorobie z ciałami lewy'ego - Google Patents
Skrócone fragmenty alfa-synukleiny w chorobie z ciałami lewy'egoInfo
- Publication number
- PL1633189T3 PL1633189T3 PL04776059T PL04776059T PL1633189T3 PL 1633189 T3 PL1633189 T3 PL 1633189T3 PL 04776059 T PL04776059 T PL 04776059T PL 04776059 T PL04776059 T PL 04776059T PL 1633189 T3 PL1633189 T3 PL 1633189T3
- Authority
- PL
- Poland
- Prior art keywords
- synuclein
- alpha
- lewy body
- body disease
- truncated fragments
- Prior art date
Links
- 208000009829 Lewy Body Disease Diseases 0.000 title 1
- 201000002832 Lewy body dementia Diseases 0.000 title 1
- 102000003802 alpha-Synuclein Human genes 0.000 title 1
- 108090000185 alpha-Synuclein Proteins 0.000 title 1
- 239000012634 fragment Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Public Health (AREA)
- Crystallography & Structural Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biodiversity & Conservation Biology (AREA)
- Toxicology (AREA)
- Animal Husbandry (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Analytical Chemistry (AREA)
- Psychology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47192903P | 2003-05-19 | 2003-05-19 | |
| PCT/US2004/015836 WO2005013889A2 (en) | 2003-05-19 | 2004-05-19 | Truncated fragments of alpha-synuclein in lewy body disease |
| EP04776059.0A EP1633189B1 (en) | 2003-05-19 | 2004-05-19 | Truncated fragments of alpha-synuclein in lewy body disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1633189T3 true PL1633189T3 (pl) | 2017-12-29 |
Family
ID=34135040
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04776059T PL1633189T3 (pl) | 2003-05-19 | 2004-05-19 | Skrócone fragmenty alfa-synukleiny w chorobie z ciałami lewy'ego |
| PL10189868T PL2361928T3 (pl) | 2003-05-19 | 2004-05-19 | Skrócone fragmenty alfa-synukleiny w chorobie z ciałami Lewy'ego |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10189868T PL2361928T3 (pl) | 2003-05-19 | 2004-05-19 | Skrócone fragmenty alfa-synukleiny w chorobie z ciałami Lewy'ego |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7306945B2 (pl) |
| EP (2) | EP1633189B1 (pl) |
| JP (2) | JP4820291B2 (pl) |
| CA (1) | CA2526900C (pl) |
| CY (2) | CY1119133T1 (pl) |
| DK (2) | DK2361928T3 (pl) |
| ES (2) | ES2632216T3 (pl) |
| HU (2) | HUE035044T2 (pl) |
| PL (2) | PL1633189T3 (pl) |
| PT (2) | PT2361928T (pl) |
| SI (2) | SI1633189T1 (pl) |
| WO (1) | WO2005013889A2 (pl) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040146521A1 (en) * | 1999-06-01 | 2004-07-29 | Schenk Dale B. | Prevention and treatment of synucleinopathic disease |
| US20080014194A1 (en) | 2003-10-31 | 2008-01-17 | Elan Pharmaceuticals, Inc. | Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease |
| US8697082B2 (en) | 2002-11-01 | 2014-04-15 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
| US8506959B2 (en) * | 2002-11-01 | 2013-08-13 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
| US9034337B2 (en) | 2003-10-31 | 2015-05-19 | Prothena Biosciences Limited | Treatment and delay of outset of synucleinopathic and amyloidogenic disease |
| TW200509968A (en) * | 2002-11-01 | 2005-03-16 | Elan Pharm Inc | Prevention and treatment of synucleinopathic disease |
| US7358331B2 (en) * | 2003-05-19 | 2008-04-15 | Elan Pharmaceuticals, Inc. | Truncated fragments of alpha-synuclein in Lewy body disease |
| US7550649B2 (en) | 2003-10-30 | 2009-06-23 | Taisho Pharmaceutical Co., Ltd. | Transgenic non-human mammal |
| WO2005047860A2 (en) | 2003-11-08 | 2005-05-26 | Elan Pharmaceuticals, Inc. | Antibodies to alpha-synuclein |
| MX2007001679A (es) | 2004-08-09 | 2007-05-23 | Elan Pharm Inc | Prevencion y tratamiento de la enfermedad sinucleinopatica y amiloidogenica. |
| US20070214509A1 (en) * | 2005-12-23 | 2007-09-13 | The Parkinson's Institute | Methods and systems for identifying compounds that modulate alpha-synuclein aggregation |
| US20090010894A1 (en) * | 2005-12-23 | 2009-01-08 | The Parkinson's Institute | Methods and systems for identifying compounds that modulate alpha-synuclein aggregation |
| PL2583978T3 (pl) | 2007-02-23 | 2016-07-29 | Prothena Biosciences Ltd Co | Profilaktyka i leczenie chorób synukleinopatycznych i amyloidogennych |
| LT3067066T (lt) | 2007-02-23 | 2019-06-25 | Prothena Biosciences Limited | Sinukleopatinių ir amiloidogeninių ligų prevencija ir gydymas |
| US8147833B2 (en) | 2007-02-23 | 2012-04-03 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
| AT506535B1 (de) * | 2008-02-22 | 2010-04-15 | Affiris Forschungs & Entwicklungs Gmbh | Vaccine enthaltend alpha-synuclein-mimotope auf basis von peptiden |
| WO2009128948A1 (en) * | 2008-04-17 | 2009-10-22 | Peptimmune, Inc. | Design and synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders |
| ES2709048T3 (es) | 2008-04-29 | 2019-04-15 | Bioarctic Ab | Anticuerpos y vacunas para su uso en métodos terapéuticos y diagnósticos para trastornos relacionados con alfasinucleína |
| AT508638B1 (de) | 2009-08-21 | 2011-08-15 | Affiris Ag | Verwendung von peptiden und polypeptiden zur behandlung und/oder prävention von synukleinopathien |
| JP6006908B2 (ja) * | 2010-11-05 | 2016-10-12 | ブランダイス ユニバーシティBrandeis University | Ice阻害化合物およびその使用 |
| EP2659906A1 (en) | 2012-05-01 | 2013-11-06 | Affiris AG | Compositions |
| EP2659908A1 (en) | 2012-05-01 | 2013-11-06 | Affiris AG | Compositions |
| EP2659907A1 (en) | 2012-05-01 | 2013-11-06 | Affiris AG | Compositions |
| WO2013173827A2 (en) * | 2012-05-18 | 2013-11-21 | Board Of Regents Of The University Of Nebraska | Methods and compositions for inhibiting diseases of the central nervous system |
| US11191832B2 (en) | 2013-11-19 | 2021-12-07 | Prothena Biosciences Limited | Monitoring immunotherapy of Lewy body disease from constipation symptoms |
| JP2017536102A (ja) | 2014-10-16 | 2017-12-07 | ジェネンテック, インコーポレイテッド | 抗アルファ−シヌクレイン抗体及び使用方法 |
| GB201512203D0 (en) | 2015-07-13 | 2015-08-19 | Lundbeck & Co As H | Agents,uses and methods |
| TW202309093A (zh) | 2016-06-02 | 2023-03-01 | 英商梅迪繆思有限公司 | 針對α-突觸核蛋白之抗體及其用途 |
| US20190227082A1 (en) * | 2016-07-06 | 2019-07-25 | Prothena Biosciences Limited | Assay for detecting total and s129 phosphorylated alpha-synuclein |
| RU2019114679A (ru) | 2016-11-15 | 2020-12-17 | Х. Лундбекк А/С | Средства, пути применения и способы лечения синуклеопатии |
| EP3555127B1 (en) | 2016-12-16 | 2024-12-18 | H. Lundbeck A/S | Agents, uses and methods |
| US10364286B2 (en) | 2016-12-22 | 2019-07-30 | H. Lundbeck A/S | Monoclonal anti-alpha-synuclein antibodies for preventing tau aggregation |
| JP7136790B2 (ja) | 2017-02-17 | 2022-09-13 | ブリストル-マイヤーズ スクイブ カンパニー | アルファ-シヌクレインに対する抗体およびその使用 |
| GB201720970D0 (en) | 2017-12-15 | 2018-01-31 | Ucb Biopharma Sprl | Antibodies |
| GB201720975D0 (en) | 2017-12-15 | 2018-01-31 | Ucb Biopharma Sprl | Anti-alpha synuclein antibodies |
| EP3752840A4 (en) * | 2018-02-12 | 2022-08-10 | The Scripps Research Institute | PROCEDURES RELATED TO PARKINSON'S DISEASE AND SYNUCLEINOPATHIES |
| CN112105393A (zh) | 2018-05-16 | 2020-12-18 | 爱默蕾大学 | 苯乙烯基苯并噻唑衍生物及在成像中的用途 |
| MX2021007446A (es) * | 2018-12-19 | 2021-09-08 | United Biomedical Inc | Epítopos artificiales promiscuos de linfocitos t colaboradores como estimuladores inmunes para inmunógenos peptídicos sintéticos. |
| JP7898188B2 (ja) | 2020-08-04 | 2026-07-31 | エイシー イミューン ソシエテ アノニム | 免疫原性化合物 |
| KR102505164B1 (ko) * | 2020-09-29 | 2023-02-28 | 서울대학교산학협력단 | 신경퇴행성 질환의 예방 또는 치료용 펩타이드 및 이를 포함하는 약학 조성물 |
| IL311344A (en) * | 2021-09-16 | 2024-05-01 | H Lundbeck As | Preparations and methods for the treatment of synoclinopathies |
| CN118475836A (zh) | 2021-11-01 | 2024-08-09 | 硝酸酶治疗公司 | 诊断突触核蛋白病的方法 |
| WO2024240186A1 (zh) | 2023-05-22 | 2024-11-28 | 深圳博芮健制药有限公司 | 含硫稠环化合物、含其的药物组合物、其制备方法及其应用 |
| WO2025172592A1 (en) | 2024-02-15 | 2025-08-21 | Ac Immune Sa | Alpha synuclein therapeutic vaccine |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH652145A5 (de) | 1982-01-22 | 1985-10-31 | Sandoz Ag | Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen. |
| US4634666A (en) | 1984-01-06 | 1987-01-06 | The Board Of Trustees Of The Leland Stanford Junior University | Human-murine hybridoma fusion partner |
| DE3521994A1 (de) | 1985-06-20 | 1987-01-02 | Bayer Ag | N-(2-aminoacylamido-2-desoxy-hexosyl)-amide-, -carbamate und -harnstoffe, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| WO1990014837A1 (en) | 1989-05-25 | 1990-12-13 | Chiron Corporation | Adjuvant formulation comprising a submicron oil droplet emulsion |
| EP1690935A3 (en) | 1990-01-12 | 2008-07-30 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| ES2109945T3 (es) | 1990-06-01 | 1998-02-01 | Chiron Corp | Composiciones y procedimientos para identificar moleculas biologicamente activas. |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5789650A (en) | 1990-08-29 | 1998-08-04 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5770429A (en) | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| ES2246502T3 (es) | 1990-08-29 | 2006-02-16 | Genpharm International, Inc. | Animales no humanos transgenicos capaces de producir anticuerpos heterologos. |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5877397A (en) | 1990-08-29 | 1999-03-02 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5814318A (en) | 1990-08-29 | 1998-09-29 | Genpharm International Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5874299A (en) | 1990-08-29 | 1999-02-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5871907A (en) | 1991-05-15 | 1999-02-16 | Medical Research Council | Methods for producing members of specific binding pairs |
| US5858657A (en) | 1992-05-15 | 1999-01-12 | Medical Research Council | Methods for producing members of specific binding pairs |
| EP0590058B1 (en) | 1991-06-14 | 2003-11-26 | Genentech, Inc. | HUMANIZED Heregulin ANTIBODy |
| WO1993001222A1 (fr) | 1991-07-03 | 1993-01-21 | Kanebo, Ltd. | Elastomere de polyurethane thermoplastique, procede et dispositif de production, et fibre elastique realisee a partir de cet elastomere |
| EP0604552B1 (en) | 1991-09-18 | 1997-02-12 | Affymax Technologies N.V. | Method of synthesizing diverse collections of oligomers |
| ES2136092T3 (es) | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
| DE69233109T2 (de) | 1992-01-07 | 2004-05-19 | Elan Pharmaceuticals, Inc., San Francisco | Transgene tiermodelle fur alzheimer-krankheit |
| US5733743A (en) | 1992-03-24 | 1998-03-31 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| US5604102A (en) * | 1992-04-15 | 1997-02-18 | Athena Neurosciences, Inc. | Methods of screening for β-amyloid peptide production inhibitors |
| HUT72495A (en) | 1992-10-01 | 1996-05-28 | Cold Spring Harbor Lab | Complex combinatorial chemical libraries encoded with tags |
| ATE199392T1 (de) | 1992-12-04 | 2001-03-15 | Medical Res Council | Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung |
| JPH09508353A (ja) | 1993-11-02 | 1997-08-26 | アフィマックス テクノロジーズ ナムローゼ フェンノートシャップ | 分子多様性の合成及びスクリーニング |
| US5914349A (en) | 1994-01-10 | 1999-06-22 | Teva Pharmaceutical Industries, Ltd. | Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
| JPH10500112A (ja) | 1994-05-06 | 1998-01-06 | ファーマコピーア,インコーポレイテッド | 組合せ ジヒドロベンゾピラン ライブラリー |
| US5663046A (en) | 1994-06-22 | 1997-09-02 | Pharmacopeia, Inc. | Synthesis of combinatorial libraries |
| AU753688B2 (en) | 1997-03-10 | 2002-10-24 | Ottawa Civic Loeb Research Institute | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| AU3117799A (en) * | 1998-03-30 | 1999-10-18 | Trustees Of The University Of Pennsylvania, The | Method of identifying, diagnosing and treating synuclein positive neurodegenerative disorders |
| US6184351B1 (en) * | 1998-09-25 | 2001-02-06 | Amgen Inc. | α-synuclein super-mutants accelerate α-synuclein aggregation |
| UA81216C2 (en) | 1999-06-01 | 2007-12-25 | Prevention and treatment of amyloid disease | |
| CN1440420A (zh) * | 2000-07-07 | 2003-09-03 | 万能药制药公司 | 预防神经组织损伤和治疗α-共核蛋白疾病的方法 |
| TW200509968A (en) | 2002-11-01 | 2005-03-16 | Elan Pharm Inc | Prevention and treatment of synucleinopathic disease |
-
2004
- 2004-05-19 DK DK10189868.2T patent/DK2361928T3/en active
- 2004-05-19 SI SI200432403T patent/SI1633189T1/sl unknown
- 2004-05-19 HU HUE10189868A patent/HUE035044T2/en unknown
- 2004-05-19 EP EP04776059.0A patent/EP1633189B1/en not_active Expired - Lifetime
- 2004-05-19 ES ES10189868.2T patent/ES2632216T3/es not_active Expired - Lifetime
- 2004-05-19 EP EP10189868.2A patent/EP2361928B1/en not_active Expired - Lifetime
- 2004-05-19 WO PCT/US2004/015836 patent/WO2005013889A2/en not_active Ceased
- 2004-05-19 ES ES04776059.0T patent/ES2640669T3/es not_active Expired - Lifetime
- 2004-05-19 JP JP2006514909A patent/JP4820291B2/ja not_active Expired - Lifetime
- 2004-05-19 DK DK04776059.0T patent/DK1633189T3/en active
- 2004-05-19 SI SI200432398A patent/SI2361928T1/sl unknown
- 2004-05-19 PT PT101898682T patent/PT2361928T/pt unknown
- 2004-05-19 PL PL04776059T patent/PL1633189T3/pl unknown
- 2004-05-19 CA CA2526900A patent/CA2526900C/en not_active Expired - Fee Related
- 2004-05-19 HU HUE04776059A patent/HUE034320T2/en unknown
- 2004-05-19 PL PL10189868T patent/PL2361928T3/pl unknown
- 2004-05-19 PT PT47760590T patent/PT1633189T/pt unknown
- 2004-10-19 US US10/969,335 patent/US7306945B2/en not_active Expired - Lifetime
-
2010
- 2010-09-10 JP JP2010203787A patent/JP5766923B2/ja not_active Expired - Fee Related
-
2017
- 2017-07-12 CY CY20171100744T patent/CY1119133T1/el unknown
- 2017-09-20 CY CY20171100989T patent/CY1119556T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2361928B1 (en) | 2017-04-26 |
| WO2005013889A3 (en) | 2005-04-28 |
| WO2005013889A2 (en) | 2005-02-17 |
| EP1633189B1 (en) | 2017-07-05 |
| US7306945B2 (en) | 2007-12-11 |
| CA2526900A1 (en) | 2005-02-17 |
| PT2361928T (pt) | 2017-07-21 |
| HUE035044T2 (en) | 2018-05-02 |
| SI1633189T1 (sl) | 2017-12-29 |
| HUE034320T2 (en) | 2018-02-28 |
| ES2640669T3 (es) | 2017-11-03 |
| JP4820291B2 (ja) | 2011-11-24 |
| CY1119133T1 (el) | 2018-02-14 |
| EP1633189A2 (en) | 2006-03-15 |
| JP2011033633A (ja) | 2011-02-17 |
| CY1119556T1 (el) | 2018-03-07 |
| PL2361928T3 (pl) | 2017-09-29 |
| JP5766923B2 (ja) | 2015-08-19 |
| JP2007525464A (ja) | 2007-09-06 |
| US20050198694A1 (en) | 2005-09-08 |
| CA2526900C (en) | 2015-11-24 |
| ES2632216T3 (es) | 2017-09-11 |
| EP1633189A4 (en) | 2006-07-19 |
| SI2361928T1 (sl) | 2017-07-31 |
| EP2361928A1 (en) | 2011-08-31 |
| DK1633189T3 (en) | 2017-08-21 |
| WO2005013889A9 (en) | 2005-06-02 |
| PT1633189T (pt) | 2017-10-04 |
| DK2361928T3 (en) | 2017-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI2361928T1 (sl) | Skrajšani fragmenti alfa-sinukleina pri bolezni Lewyjevih telesc | |
| GB0307918D0 (en) | Therapeutic use | |
| EP1613274A4 (en) | CONJUGATES COMPRISING THE HUMAN INTERLEUKINE 18 THERE AND 18 MUTANTS OF THESE CONJUGATES BY SUBSTITUTION | |
| AU2002362564A8 (en) | Personal body armor | |
| PL380527A1 (pl) | Terapeutyczne kombinacje przeciwciała anty-IGFR1 | |
| GB0212885D0 (en) | Therapeutic epitopes and uses thereof | |
| IL164799A0 (en) | Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality | |
| GB0316912D0 (en) | Therapeutic treatment | |
| AU2003304090A8 (en) | Dual use body armor | |
| GB0320238D0 (en) | Treatment of disease | |
| EP1675547A4 (en) | GLUCOCEREBROSIDE TREATMENT OF ILLNESSES | |
| IL175749A0 (en) | Chaperone - based therapy for niemann-pick disease | |
| IL157024A0 (en) | Il-18 inhibitors in heart disease | |
| GB0413822D0 (en) | Bone fixator | |
| AU2003298719A8 (en) | Treatment for sma disease | |
| PL1617876T3 (pl) | Tor-227 do zastosowania w radioterapii choroby tkanek miękkich | |
| ZA200606225B (en) | Modified human four helical bundle polypeptides and their uses | |
| GB0307863D0 (en) | Therapeutic treatment | |
| IL174595A0 (en) | Glucocerebroside treatment of disease | |
| GB0313772D0 (en) | Therapeutic treatment | |
| GB0215051D0 (en) | Simulated body tissue | |
| GB0409528D0 (en) | Body armour | |
| GB0325021D0 (en) | Therapeutic combinations | |
| GB0306444D0 (en) | Composition and its therapeutic use | |
| GB0322990D0 (en) | Therapeutic use |